OTCMKTS:CZMWY - Carl Zeiss Meditec Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$208.00
+0.30 (1.20%)

This chart shows the closing price for CZMWY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Carl Zeiss Meditec Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CZMWY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CZMWY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 6 analysts offering 12 month price targets for Carl Zeiss Meditec in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $208.00.

This chart shows the closing price for CZMWY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 6 polled investment analysts is to hold stock in Carl Zeiss Meditec. This rating has held steady since September 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/1/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/1/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/30/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/28/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/26/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
4/26/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
6/25/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
7/25/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/21/2021Berenberg BankReiterated RatingHold
5/27/2021Berenberg BankReiterated RatingHold
4/20/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
4/16/2021Kepler Capital MarketsUpgradeReduce ➝ Hold
2/16/2021CommerzbankUpgradeReduce ➝ Hold
2/9/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
1/22/2021DZ BankUpgradeSell ➝ Hold
1/20/2021Berenberg BankReiterated RatingHold
1/20/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
11/2/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
10/23/2020UBS GroupDowngradeBuy ➝ Neutral
7/17/2020Berenberg BankReiterated RatingHold
7/16/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
(Data available from 7/25/2016 forward)
Carl Zeiss Meditec logo
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, France, Spain, India, the United Kingdom, Turkey, North Africa, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery. This segment also offers optical coherence tomography devices, perimeters, fundus cameras, slit lamps, and therapeutic and refractive lasers for the diagnosis and treatment of various eye diseases, such as refraction, glaucoma, and other retinal diseases, as well as FORUM, an eye care data management system. The Microsurgery segment provides surgical microscopes and visualization solutions for neuro, spinal, dental, and plastic and reconstructive surgeries, as well as for ear, nose, and throat surgery; products for surgical treatment of tumors or vascular diseases, such as aneurysms; and INTRABEAM, a intraoperative radiotherapy device. Carl Zeiss Meditec AG serves ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The company was founded in 2002 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
Read More

Today's Range

Now: $208.00
Low: $208.00
High: $208.00

50 Day Range

MA: $189.95
Low: $174.00
High: $208.00

52 Week Range

Now: $208.00
Low: $103.30
High: $208.00

Volume

1,226 shs

Average Volume

653 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Carl Zeiss Meditec?

The following Wall Street research analysts have issued research reports on Carl Zeiss Meditec in the last twelve months: Berenberg Bank, Commerzbank AG, Deutsche Bank Aktiengesellschaft, DZ Bank AG, Kepler Capital Markets, and UBS Group AG.
View the latest analyst ratings for CZMWY.

What is the current price target for Carl Zeiss Meditec?

0 Wall Street analysts have set twelve-month price targets for Carl Zeiss Meditec in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Carl Zeiss Meditec in the next year.
View the latest price targets for CZMWY.

What is the current consensus analyst rating for Carl Zeiss Meditec?

Carl Zeiss Meditec currently has 5 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CZMWY, but not buy more shares or sell existing shares.
View the latest ratings for CZMWY.

What other companies compete with Carl Zeiss Meditec?

How do I contact Carl Zeiss Meditec's investor relations team?

The company's listed phone number is 49 3641 220 115. The official website for Carl Zeiss Meditec is www.zeiss.com.